Minimal residual disease in acute lymphoblastic leukemia

D Campana - Hematology 2010, the American Society of …, 2010 - ashpublications.org
In patients with acute lymphoblastic leukemia (ALL), treatment response is increasingly
evaluated with minimal residual disease (MRD) assays. ALL cells can be recognized by …
被引用次数：283 相关文章

Minimal Residual Disease in Acute Lymphoblastic Leukemia

D Campana - Hematology, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> In patients with acute lymphoblastic leukemia
(ALL), treatment response is increasingly evaluated with minimal residual disease (MRD) …
[PDF] archive.org

[PDF][PDF] Minimal Residual Disease in Acute Lymphoblastic Leukemia

D Campana - Hematology, 2010 - scholar.archive.org
In patients with acute lymphoblastic leukemia (ALL), treatment response is increasingly
evaluated with minimal residual disease (MRD) assays. ALL cells can be recognized by …

Minimal residual disease in acute lymphoblastic leukemia.

D Campana - … . American Society of Hematology. Education Program, 2010 - europepmc.org
In patients with acute lymphoblastic leukemia (ALL), treatment response is increasingly
evaluated with minimal residual disease (MRD) assays. ALL cells can be recognized by …

Minimal residual disease in acute lymphoblastic leukemia

D Campana - Hematology. American Society of …, 2010 - pubmed.ncbi.nlm.nih.gov
In patients with acute lymphoblastic leukemia (ALL), treatment response is increasingly
evaluated with minimal residual disease (MRD) assays. ALL cells can be recognized by …

[引用][C] Minimal residual disease in acute lymphoblastic leukemia

D CAMPANA - Hematology Am Soc Hmatol Educ Program. 2010, 2010 - cir.nii.ac.jp